BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6847725)

  • 1. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus.
    Abramson SB; Given WP; Edelson HS; Weissmann G
    Arthritis Rheum; 1983 May; 26(5):630-6. PubMed ID: 6847725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neutrophil-dependent inflammatory reactions in systemic lupus erythematosus].
    Sarano JF; Said P; Llera A; Prat A; Boveris A; Casellas A; Manni JA
    Medicina (B Aires); 1989; 49(2):113-8. PubMed ID: 2640479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel assay for neutrophil clustering activity of human sera: relation to disease activity and neutropenia in systemic lupus erythematosus.
    Jonsson H; Sturfelt G
    Ann Rheum Dis; 1990 Jan; 49(1):46-50. PubMed ID: 2310227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of C5-derived peptides and other immune reactants in the sera of patients with systemic lupus erythematosus.
    Given WP; Edelson HS; Kaplan HB; Aisen P; Weissmann G; Abramson SB
    Arthritis Rheum; 1984 Jun; 27(6):631-7. PubMed ID: 6732883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera.
    Hashimoto Y; Ziff M; Hurd ER
    Arthritis Rheum; 1982 Dec; 25(12):1409-18. PubMed ID: 6293513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
    Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
    Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell destruction by polymorphonuclear leukocytes incubated with sera from patients with systemic lupus erythematosus (SLE).
    Hashimoto Y; Nakano K; Yoshinoya S; Tanimoto K; Itoh K
    Scand J Rheumatol; 1992; 21(5):209-14. PubMed ID: 1439628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
    Starkebaum G; Arend WP
    J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
    Park YB; Lee SK; Kim DS; Lee J; Lee CH; Song CH
    Clin Exp Rheumatol; 1998; 16(3):283-8. PubMed ID: 9631750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus.
    Nived O; Linder C; Odeberg H; Svensson B
    Ann Rheum Dis; 1985 Apr; 44(4):252-9. PubMed ID: 3872638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus.
    Lim MK; Lee CK; Ju YS; Cho YS; Lee MS; Yoo B; Moon HB
    Rheumatol Int; 2001 Apr; 20(3):89-93. PubMed ID: 11354563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.
    Bertouch JV; Roberts-Thompson PJ; Feng PH; Bradley J
    Ann Rheum Dis; 1983 Dec; 42(6):655-8. PubMed ID: 6606401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.